Prescription drug · ANDA
brivaracetam NDC 73473-906
Brivaracetam 50 mg/1 · Tablet, Film coated · Oral · SolarisPharmaCorporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73473-906-60 | 73473090660 | 60 TABLET, FILM COATED in 1 BOTTLE (73473-906-60)Marketed from Feb 4, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- brivaracetam
- Generic name (nonproprietary)
- brivaracetam
- Active ingredients
- Brivaracetam — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- SolarisPharmaCorporation
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214748
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 73473-906_582096b8-9351-949b-e063-6394a90ad460SPL ID 582096b8-9351-949b-e063-6394a90ad460SPL set ID 49f726ec-e51b-7516-e063-6294a90ae684RxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0373473907603, 0373473906606, 0373473905609, 0373473908600
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473473090660followed by a unit qualifier and the quantityPackage 73473-0906-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214748
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| brivaracetam | Brivaracetam 10 mg/1 | Tablet, Film coatedOral | SolarisPharmaCorporation | 73473-904 |
| brivaracetam | Brivaracetam 100 mg/1 | Tablet, Film coatedOral | SolarisPharmaCorporation | 73473-908 |
| brivaracetam | Brivaracetam 25 mg/1 | Tablet, Film coatedOral | SolarisPharmaCorporation | 73473-905 |
| brivaracetam | Brivaracetam 75 mg/1 | Tablet, Film coatedOral | SolarisPharmaCorporation | 73473-907 |